Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Enzo Biochem reports results for third fiscal quarter
July 14th, 2006
Enzo Biochem, Inc. (ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, reported operating results for the fiscal three and nine months ended April 30, 2006. "While we continue to make progress at Enzo Therapeutics and in the growth of our intellectual property base, price competition and continuing litigation expenses impacted operating results during the third quarter," said Barry Weiner, president. "Our focus remains on growing the company, and broadening our operating scope with new products." The recent addition of new, highly experienced...
Source: Genomics & Genetics Weekly (2006-07-14)
|
